Several recent studies have focused on the diagnostic and prognostic significance of CD24 and CD44 expression in human cancers[17–19], and the roles of CD24 and CD44 in gastric carcinoma have also been explored[6, 11, 20, 21]. This evidence concerns the gene CD44 and gastric carcinoma.